Related Experiment Video
Updated: Jul 15, 2026
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
The First Treatment for PKU: The Pioneers-Birmingham 1951
1Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
Insights
Phenylketonuria (PKU) treatment was revolutionized in 1951 with a special diet, enabling affected individuals to live normal lives. This breakthrough paved the way for newborn screening programs worldwide.
Area of Science:
- Medical History
- Genetics
- Public Health
Background:
- Phenylketonuria (PKU) historically led to severe intellectual disability and institutionalization.
- Effective treatment for PKU was unknown before the mid-20th century.
- The development of a dietary intervention was crucial for improving outcomes in PKU patients.
Purpose of the Study:
- To review the historical development of Phenylketonuria (PKU) treatment.
- To highlight the pivotal role of early dietary interventions in PKU management.
- To recognize the pioneers of PKU treatment and their impact on newborn screening.
Main Methods:
- Historical review of Phenylketonuria (PKU) management.
- Analysis of the impact of early dietary interventions.
- Case study of the 1951 Birmingham, UK team and their contributions.
Main Results:
- A modified diet developed in 1951 proved effective in treating Phenylketonuria (PKU).
- Affected individuals could lead normal lives with early dietary intervention.
- This success was a catalyst for the implementation of newborn screening for PKU.
Conclusions:
- The 1951 dietary intervention for Phenylketonuria (PKU) marked a turning point in metabolic disorder treatment.
- The Birmingham team's work directly led to the establishment of newborn screening programs.
- Pioneering efforts in PKU treatment transformed patient outcomes and public health strategies.
Abstract:
Prior to the introduction of newborn screening, Phenylketonuria (PKU) was a devastating disorder with affected individuals usually committed to a life in care in large institutions (asylums). Newborn screening only began after it was shown that those with PKU could be treated with a modified diet and could subsequently lead normal lives. The first production of a diet and the demonstration of its effectiveness was thus a key milestone in the history of both PKU and newborn screening, and took place in Birmingham, UK, in 1951. The pioneers were a two-year-old girl called Sheila Jones, her mother Mary, and three dedicated professionals at Birmingham Children's Hospital: Evelyn Hickmans, John Gerrard and Horst Bickel. Together, they changed the course of PKU for those across the world. This review summarises the history and achievements of this team who opened the door to PKU treatment and the introduction of newborn screening.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
11:20Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
